STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-γ-induced Apoptosis in Urothelial Cancer.
Fuchizawa H, Ando K, Motoi N, Iizuka T, Inoue M, Mitani K, Sano Y, Takenobu H, Haruta M, Onuki R, Matsuoka Y, Kamijo T, Kageyama Y.
Fuchizawa H, et al. Among authors: kageyama y.
Anticancer Res. 2024 May;44(5):1925-1930. doi: 10.21873/anticanres.16994.
Anticancer Res. 2024.
PMID: 38677727